Found 8 matching trials
Study of the Combination of a Tyrosine Kinase Inhibitor (STI571) and a Pegylated Human Recombinant Interferon alfa2b (PEGINTRON)
PHASE2This is a phase II multicenter, open-label study designed to investigate th...
Location
Multiple Locations
Study of Imatinib and Peginterferon α-2b in Gastrointestinal Stromal Tumor (GIST) Patients
PHASE2Imatinib (IM) has dramatically improved survival of gastrointestinal stroma...
Location
University of Utah
A Study Comparing Imatinib and Imatinib/Pegylated Interferon in Chronic Myeloid Leukemia
PHASE2Patients with chronic myeloid leukemia in imatinib induced CHR are randomiz...
High-Dose Gleevec Alone or in Combination With Peg-Intron and GM-CSF in Early Phase Chronic Myelogenous Leukemia (CML)
PHASE3The goal of this clinical research study is to learn if giving PEG-Alpha In...
Location
University of Texas MD Anderson Cancer Center
Proteinase 3 PR1 Peptide Mixed With Montanide ISA-51 VG Adjuvant and Administered With GM-CSF and PEG-INTRON(R)
PHASE2The goal of this clinical research study is to find out if using the PR1 pe...
Location
UT MD . Anderson Cancer Center
Pegylated Interferon Alfa-2b and Nilotinib for Augmentation of Complete Molecular Response in Chronic Myeloid Leukaemia
PHASE2The treatment of CML and the expected survival has been revolutionised sinc...
Location
Royal Adelaide Hospital
Addition of P1101 to Imatinib Treatment in Patients With Chronic Phase Chronic Myeloid Leukaemia Not Achieving a Complete Molecular Response
PHASE1In this phase I pilot study, it is planned to investigate the feasibility a...
Location
Klinikum Wels-Grieskirchen GmbH, IV. Interne Abteilung
Imatinib or Nilotinib With Pegylated Interferon-α2b in Chronic Myeloid Leukemia
PHASE2To investigate whether patients with chronic-phase chronic myeloid leukemia...
Location
Universtiy of Michigan